Pałaszewska-Tkacz Anna, Czerczak Sławomir, Konieczko Katarzyna, Kupczewska-Dobecka Małgorzata
Nofer Institute of Occupational Medicine, Łódź, Poland (Department of Chemical Safety).
Int J Occup Med Environ Health. 2019 Apr 3;32(2):141-159. doi: 10.13075/ijomeh.1896.01248. Epub 2019 Mar 19.
Cytostatics not only induce significant side-effects in patients treated oncologically but also pose a threat to the health of occupationally exposed healthcare workers: pharmacists, physicians, nurses and other personnel. Since the 1970s numerous reports from various countries have documented the contamination of working areas with cytostatics and the presence of drugs/metabolites in the urine or blood of healthcare employees, which directly indicates the occurrence of occupational exposure to these drugs. In Poland the significant scale of occupational exposure to cytostatics is also confirmed by the data collected in the central register of occupational carcinogens/mutagens kept by the Nofer Institute of Occupational Medicine. The assessment of occupational exposure to cytostatics and health risks constitutes employers' obligation. Unfortunately, the assessment of occupational risk resulting from exposure to cytostatics raises a number of concerns. Provisions governing the problem of workers' health protection are not unequivocal because they derive from a variety of law areas, especially in a matter of hazard classification and safety data sheets for cytostatics. Moreover, no legally binding occupational exposure limits have been set for cytostatics or their active compounds, and analytical methods for these substances airborne and biological concentrations are lacking. Consequently, the correct assessment of occupational exposure to cytostatics, the evaluation of health hazards and the development of the proper preventive strategy appear difficult. The authors of this article described and discussed the amendments to the European provisions concerning chemicals in the light of employers' obligations in the field of employees' heath protection against the consequences of exposure to cytostatics. Some modifications aimed at a more effective health protection of workers occupationally exposed to cytostatics were also proposed. Int J Occup Med Environ Health. 2019;32(2):141-59.
细胞毒性药物不仅会给接受肿瘤治疗的患者带来严重的副作用,还会对职业暴露的医护人员(药剂师、医生、护士及其他人员)的健康构成威胁。自20世纪70年代以来,各国的大量报告记录了工作区域被细胞毒性药物污染的情况,以及医护人员尿液或血液中存在药物/代谢物,这直接表明了这些药物职业暴露的发生。在波兰,职业医学诺费尔研究所保存的职业致癌物/诱变剂中央登记册收集的数据也证实了细胞毒性药物职业暴露的规模之大。评估细胞毒性药物的职业暴露和健康风险是雇主的义务。不幸的是,评估细胞毒性药物暴露导致的职业风险引发了诸多担忧。关于工人健康保护问题的规定并不明确,因为它们源自多个法律领域,尤其是在细胞毒性药物的危害分类和安全数据表方面。此外,尚未为细胞毒性药物或其活性成分设定具有法律约束力的职业接触限值,并且缺乏针对这些物质空气传播浓度和生物浓度的分析方法。因此,正确评估细胞毒性药物的职业暴露、评估健康危害以及制定适当的预防策略似乎都很困难。本文作者根据雇主在保护员工免受细胞毒性药物暴露后果方面的义务,描述并讨论了欧洲化学品相关规定的修订情况。还提出了一些旨在更有效地保护职业接触细胞毒性药物工人健康的修改建议。《国际职业医学与环境卫生杂志》。2019年;32(2):141 - 59。